Profilaxis de la encefalopatía hepática
暂无分享,去创建一个
[1] M. Miquel,et al. Rifaximin, but not growth factor 1, reduces brain edema in cirrhotic rats. , 2012, World journal of gastroenterology.
[2] M. Miquel,et al. Rat CCl4‐induced cirrhosis plus total portal vein ligation: a new model for the study of hyperammonaemia and brain oedema , 2010, Liver international : official journal of the International Association for the Study of the Liver.
[3] A. Sanyal,et al. 195 RIFAXIMIN DECREASES VENOUS AMMONIA CONCENTRATIONS AND TIME-WEIGHTED AVERAGE AMMONIA CONCENTRATIONS CORRELATE WITH OVERT HEPATIC ENCEPHALOPATHY (HE) AS ASSESSED BY CONN SCORE IN A 6-MONTH STUDY , 2010 .
[4] A. Sanyal,et al. 15 RIFAXIMIN TREATMENT IMPROVED QUALITY OF LIFE IN PATIENTS WITH HEPATIC ENCEPHALOPATHY: RESULTS OF A LARGE, RANDOMIZED, PLACEBO-CONTROLLED TRIAL , 2010 .
[5] C. Leevy,et al. Rifaximin treatment in hepatic encephalopathy. , 2010, The New England journal of medicine.
[6] J S Bajaj,et al. Review article: the modern management of hepatic encephalopathy , 2010, Alimentary pharmacology & therapeutics.
[7] B. Sharma,et al. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. , 2009, Gastroenterology.
[8] Darego O. Maclayton,et al. Rifaximin for Treatment of Hepatic Encephalopathy , 2009, The Annals of Pharmacotherapy.
[9] J. Alcorn. Review: Rifaximin is equally or more effective than other antibiotics and lactulose for hepatic encephalopathy , 2008, Annals of Internal Medicine.
[10] M. Zheng,et al. Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis , 2008, European journal of gastroenterology & hepatology.
[11] K. Lawrence,et al. Rifaximin for the Treatment of Hepatic Encephalopathy , 2008, Pharmacotherapy.
[12] L. Gluud,et al. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials , 2004, BMJ : British Medical Journal.
[13] R Williams,et al. Treatment of hepatic encephalopathy. , 1997, The New England journal of medicine.